Australia - English - Department of Health (Therapeutic Goods Administration)

little green pharma ltd - tetrahydrocannabinol, quantity: 1 mg/ml; cannabidiol, quantity: 20 mg/ml - oral liquid - excipient ingredients: medium chain triglycerides - there is growing evidence that medicinal cannabis can benefit patients in a variety of clinical settings. based on this, the lgp classic oil range including 1:20 lgp classic, as a medicinal cannabis product, may have a role in medical conditions including: ? intractable epileptic seizures in adults and children, ? intractable chronic pain insufficiently responsive to other analgesics ? pain associated with spasticity in multiple sclerosis ? pain associated with cancer in palliative care ? cancer treatment-induced nausea and vomiting ? appetite loss ? insomnia ? post-traumatic stress disorder ? cachexia

Australia - English - Department of Health (Therapeutic Goods Administration)

little green pharma ltd - cannabidiol, quantity: 20 mg/ml; tetrahydrocannabinol, quantity: 1 mg/ml - oral liquid - excipient ingredients: medium chain triglycerides - there is growing evidence that medicinal cannabis can benefit patients in a variety of clinical settings. based on this, the lgp classic oil range including 10:10 lgp classic, and 20:5 lgp classic as medicinal cannabis products, may have a role in medical conditions including:behavioural issues associated with autism, ? intractable epileptic seizures in adults and children, ? intractable chronic pain insufficiently responsive to other analgesics ? pain associated with spasticity in multiple sclerosis ? pain associated with cancer in palliative care ? cancer treatment-induced nausea and vomiting ? appetite loss ? insomnia ? post-traumatic stress disorder ? cachexia

Australia - English - Department of Health (Therapeutic Goods Administration)

ecs botanics mc pty ltd - tetrahydrocannabinol, quantity: 20 mg/ml; cannabidiol, quantity: 1 mg/ml - oil - excipient ingredients:

Australia - English - Department of Health (Therapeutic Goods Administration)

montu group pty ltd - cannabidiol, quantity: 1 mg/ml; tetrahydrocannabinol, quantity: 20 mg/ml - oil - excipient ingredients: medium chain triglycerides

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

gw pharma ltd - cannabidiol; dronabinol - spray - 2.5mg/1dose ; 2.7mg/1dose

Australia - English - Department of Health (Therapeutic Goods Administration)

cannim australia pty ltd - tetrahydrocannabinol, quantity: 0.318 ml; cannabidiol, quantity: 0.318 ml - oil - excipient ingredients: medium chain triglycerides

Australia - English - Department of Health (Therapeutic Goods Administration)

cannim australia pty ltd - tetrahydrocannabinol, quantity: 0.858 ml; cannabidiol, quantity: 0.033 ml - oil - excipient ingredients: medium chain triglycerides

Australia - English - Department of Health (Therapeutic Goods Administration)

cannim australia pty ltd - tetrahydrocannabinol, quantity: 0.318 ml; cannabidiol, quantity: 0.318 ml - oil - excipient ingredients: medium chain triglycerides

Australia - English - Department of Health (Therapeutic Goods Administration)

cannim australia pty ltd - tetrahydrocannabinol, quantity: 0.795 ml; cannabidiol, quantity: 0.033 ml - oil - excipient ingredients: medium chain triglycerides

Ireland - English - HPRA (Health Products Regulatory Authority)

gw pharma (international) b.v. - delta-9-tetrahydrocannabinol botanical drug substance (thc bds); cannabidiol botanical drug substance (cbd bds) - oromucosal spray, solution - 27 mg/ml + 25 milligram(s)/millilitre - other analgesics and antipyretics; cannabinoids